Like CA3 treatment, TED-347 treatment did not affect blood vessel density but decreased VM density in melanoma brain tumor specimens (Supplementary Fig. 12i–k) These data suggest that drugs targeting YAP/TAZ could have activity in melanoma brain and extracranial metastases and enhance survival, which might be linked to their inhibitory effects on VM. Here, YAP1 is linked to melanoma.